Impact of Weight Loss After a Bypass Surgery on Renal Hemodynamic Under Stress Conditions

NCT ID: NCT02218112

Last Updated: 2018-03-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

36 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-06-30

Study Completion Date

2017-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The sympathetic nervous (SNS) and the renin angiotensin aldosterone system (RAS) have a direct impact on renal hemodynamic, hormonal secretion and vasoactive peptide. Many mechanisms including the SNS, RAS and renal sodium handling could explain the pathogenesis of hypertension in obese patients. Lifestyle changes and bariatric surgery induce weight loss, which is associated with blood pressure lowering in obese patients. A diminution in the renal sympathetic stimulation and RAS activation could explain this effect.

The AIM of this study is to show that weight loss induced by bypass surgery in obese patients affects renal salt excretion under " low body negative pressure (LBNP)" conditions .

Secondary objectives are to investigate the impact of weight loss on renal hemodynamic (glomerular filtration rate (GFR), renal plasma flow) and neurohormonal responses under " low body negative pressure conditions ". We will also analyse renal blood oxygenation with Blood Oxygenation dependant IRM (BOLD-IRM) technique before and after weight loss.

The population of this study will consist in two groups including 36 patients. The first one will include 24 obese patients that are going to undergo a bariatric surgery. The second one will include 12 obese patients without any weight loss associated surgery.

Both group will undergo 3 investigation days. Each patient will have to undergo a screening visit that will provide dietary advice to ensure a standardized salt intake (120-180 mmol/day) for the duration of the study. The first investigation will define baseline, the second and third day of investigation will take place after 3 month and 12 month after bariatric surgery for surgical patients or after baseline for patients without surgery. One to two weeks before phase 1 and 3 patients will perform a BOLD-MRI. The surgery group will undergo bariatric surgery between the first investigation phase (baseline) and the second. An ambulatory blood pressure and 24-hour urine collection will precede each investigation day. An investigation day consists in renal hemodynamics, neurohormonal and natriuretic response measurements before, during and after 60 min of LBNP at -30mbar . The duration of the study per subject is going to take 12 months.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity Bariatric Surgery Blood Pressure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

OB - Bariatric surgery (gastric bypass)

Obese patients who will undergo a bariatric surgery (gastric bypass)

bariatric surgery (gastric bypass)

Intervention Type PROCEDURE

OB- Control group

Obese patients who will not undergo surgery - Control group

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

bariatric surgery (gastric bypass)

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* BMI \>35 Kg/m2
* Understanding and signing the informed consent
* Estimated glomerular filtration rate \>60 ml/min/1.73 m2

Exclusion Criteria

* Acute disease
* Asthma or history of asthma
* Patient participating in another clinical trial 30 days before the beginning of the study
* Blood donation (450ml) 2 months before the beginning of the study
* Chronic medication which influence renal function (NSAIDS, Others)
* Allergy
* Documented renal arterial stenosis
* History of symptomatic orthostatic hypotension
* Kidney transplantation
* Kidney malformation / polycystic kidney disease
* Impaired judgement
* Liver failure with ascitis
* Hip circumference at the upper anterior iliac spine \> 130cm
* Waist circumference \>180cm and weighing \> 220kg
* Contraindication/Allergy to furosemide, PAH or Inulin
* Contraindication to MRI if the patient is going to undergo BOLD-MRI
* Postprandial glycemia \> 11.0 mmol/L in diabetic patients
* Blood pressure \> 180/110 assessed by 24 hour blood pressure measurement
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire Vaudois

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

PD Dr. Grégoire Wuerzner

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Hospitalier Universitaire Vaudois

Lausanne, Canton of Vaud, Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

References

Explore related publications, articles, or registry entries linked to this study.

Zahnd J, Vakilzadeh N, Schwotzer N, Hendriks-Balk M, Mantziari S, Sauser J, Maillard M, Grouzmann E, Favre L, Wuerzner G. Weight loss following gastric bypass increases aldosterone reactivity to orthostatic stress in patients with obesity. Blood Press. 2025 Dec;34(1):2555452. doi: 10.1080/08037051.2025.2555452. Epub 2025 Sep 16.

Reference Type DERIVED
PMID: 40892437 (View on PubMed)

Berney M, Vakilzadeh N, Maillard M, Faouzi M, Grouzmann E, Bonny O, Favre L, Wuerzner G. Bariatric Surgery Induces a Differential Effect on Plasma Aldosterone in Comparison to Dietary Advice Alone. Front Endocrinol (Lausanne). 2021 Oct 5;12:745045. doi: 10.3389/fendo.2021.745045. eCollection 2021.

Reference Type DERIVED
PMID: 34675881 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SNF_ 32003B_149903

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.